IDEAS home Printed from https://ideas.repec.org/a/rfa/journl/v4y2016i9p49-60.html
   My bibliography  Save this article

How Investors Survive in Crony Capitalism: A Case Study of OBI Pharma Inc. in Taiwan

Author

Listed:
  • Yu-wei Lan
  • Dan Lin
  • Lu Lin

Abstract

The development of big data research methods and the information asymmetry problems in the financial market lead to the new issue of homo sociologicus, which has become a new way of thinking and has hoped to find the cause of asset pricing problem in the market. Crony capitalism is prevalent in the emerging and developing countries. It leads to wealth inequalities. Therefore, behavioral finance theory can help individual investors make investment decisions and help stock prices to reflect their true values. This study finds that the biotechnology industry does not exist an efficient market based on two OTC biotech companies, OBI Pharma and TaiMed Biologics, for the period 2015.11.23~2016.6.7. The results show that the technical analysis tested in this study can lead to trading profits and investors can increase their trading profits based on the mean reversion characteristic of company price differences.

Suggested Citation

  • Yu-wei Lan & Dan Lin & Lu Lin, 2016. "How Investors Survive in Crony Capitalism: A Case Study of OBI Pharma Inc. in Taiwan," International Journal of Social Science Studies, Redfame publishing, vol. 4(9), pages 49-60, September.
  • Handle: RePEc:rfa:journl:v:4:y:2016:i:9:p:49-60
    as

    Download full text from publisher

    File URL: http://redfame.com/journal/index.php/ijsss/article/view/1740/1841
    Download Restriction: no

    File URL: http://redfame.com/journal/index.php/ijsss/article/view/1740
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    mean reversion; program trading; Granger causality test; crony capitalism; biotech industry; efficient market;
    All these keywords.

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rfa:journl:v:4:y:2016:i:9:p:49-60. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Redfame publishing (email available below). General contact details of provider: https://edirc.repec.org/data/cepflch.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.